Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound-Reference-Cited by-同舟云学术

Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound

Published:1991 Issue:3 Volume:22 Page:239-250
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Sánchez Connie,Arnt Jørn,Dragsted Nils,Hyttel John,Lembøl Hanne Løve,Meier Eddi,Perregaard Jens,Skarsfeldt Torben

Publisher

Wiley

Subject

Drug Discovery

Reference38 articles.

1. In vivo pharmacology of irindalone, a 5-HT2 receptor antagonist with predominant peripheral effects;Arnt;Drug Dev. Res.,1989

2. Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potential;Arnt;Neuro-pharmacology,1981

3. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine antagonists in rats with unilateral 6-hydroxy dopamine lesions;Arnt;Eur. J. Pharmacol.,1984

4. Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro;Arnt;J. Neural. Transm.,1986

5. Biochemical processes in schizophrenia: An update;Bowers;Schizophr. Bull.,1980

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2024

2. Antibacterial and Antibiofilm Activities of Sertindole and Its Antibacterial Mechanism against Staphylococcus aureus;ACS Omega;2023-02-03

3. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2023

4. Exploring the kinetic selectivity of antipsychotics for dopamine D2 and 5-HT2A receptors: implications for the prevalence of EPS and receptor occupancy;2021-11-14

5. Photodegradation Study of Sertindole by UHPLC-ESI-Q-TOF and Influence of Some Metal Oxide Excipients on the Degradation Process;Pharmaceutics;2019-06-27